What does Dokter I de Wergifosse do?

Dokter I de Wergifosse is a general practice in Hasselt. Private Limited, started on 27 October 2017, 1 establishment.

What is the address of Dokter I de Wergifosse?

The registered office of Dokter I de Wergifosse is located at Sint-Truidersteenweg 109, 3500 Hasselt.

Is Dokter I de Wergifosse still active?

Yes. According to the CBE (19 September 2026) Dokter I de Wergifosse is active, legal situation “Normale toestand”, started on 27 October 2017.

Is Dokter I de Wergifosse registered on Peppol?

Yes, Dokter I de Wergifosse is registered on the Peppol network with ID 0208:0683804171.

What is the enterprise number of Dokter I de Wergifosse?

The enterprise number of Dokter I de Wergifosse is BE0683804171.

When was Dokter I de Wergifosse founded?

Dokter I de Wergifosse was founded on 27 October 2017.

Who are the directors of Dokter I de Wergifosse?

According to the 2025 annual accounts, the directors of Dokter I de Wergifosse are: Isabelle de Wergifosse.

Is Dokter I de Wergifosse a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 October 2017; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dokter I de Wergifosse make in 2025?

Dokter I de Wergifosse posted a profit after taxes of € 149,066 in financial year 2025.

What is the revenue of Dokter I de Wergifosse?

As a small company, Dokter I de Wergifosse is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 196,654.

Dokter I de Wergifosse (Private Limited) - Hasselt

Dossier Dokter I de Wergifosse, printed on 19 September 2026 from databakkes.be/en/0683804171/dokter-i-de-wergifosse. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dokter I de Wergifosse from Hasselt, company number BE0683804171, closed financial year 2025 with a result of € 149,066 after tax. For that financial year Dokter I de Wergifosse recorded a gross margin of € 196,654 and equity of € 18,600. Compared with financial year 2024, the result moved from € 160,131 to € 149,066. The company is profitable. The buffer shrank hard: equity is 84 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 6, 2026.

What it is worth Shrank hard

€ 18,600

▼ 84% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 149,066

▼ 7% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 152,067

▼ 2% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 247,820 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 17,442

▲ 36% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 67

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 48

▼ 97% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 8,594

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 140,087 Gross margin 2022: € 140,087 First fiscal year in the series	€ 152,003 Gross margin 2023: € 152,003 ▲ 9% vs 2022 (€ 140,087) Favourable step	€ 210,163 Gross margin 2024: € 210,163 ▲ 38% vs 2023 (€ 152,003) Favourable step	€ 196,654 Gross margin 2025: € 196,654 ▼ 6% vs 2024 (€ 210,163) Unfavourable step	▼ 6%
Profit after taxes	€ 103,434 Profit after taxes 2022: € 103,434 First fiscal year in the series	€ 115,018 Profit after taxes 2023: € 115,018 ▲ 11% vs 2022 (€ 103,434) Favourable step	€ 160,131 Profit after taxes 2024: € 160,131 ▲ 39% vs 2023 (€ 115,018) Favourable step	€ 149,066 Profit after taxes 2025: € 149,066 ▼ 7% vs 2024 (€ 160,131) Unfavourable step	▼ 7%
Equity	€ 117,354 Equity 2022: € 117,354 First fiscal year in the series	€ 117,354 Equity 2023: € 117,354 Unchanged (€ 117,354) Unchanged	€ 117,354 Equity 2024: € 117,354 Unchanged (€ 117,354) Unchanged	€ 18,600 Equity 2025: € 18,600 ▼ 84% vs 2024 (€ 117,354) Unfavourable step	▼ 84%
Total debts	€ 116,036 Total debts 2022: € 116,036 First fiscal year in the series	€ 125,529 Total debts 2023: € 125,529 ▲ 8% vs 2022 (€ 116,036) Unfavourable step	€ 173,338 Total debts 2024: € 173,338 ▲ 38% vs 2023 (€ 125,529) Unfavourable step	€ 197,770 Total debts 2025: € 197,770 ▲ 14% vs 2024 (€ 173,338) Unfavourable step	▲ 14%
Cash	€ 222,349 Cash 2022: € 222,349 First fiscal year in the series	€ 114,953 Cash 2023: € 114,953 ▼ 48% vs 2022 (€ 222,349) Unfavourable step	€ 154,680 Cash 2024: € 154,680 ▲ 35% vs 2023 (€ 114,953) Favourable step	€ 152,067 Cash 2025: € 152,067 ▼ 2% vs 2024 (€ 154,680) Unfavourable step	▼ 2%
Land & buildings	€ 4,385 Land & buildings 2022: € 4,385 First fiscal year in the series	€ 3,868 Land & buildings 2023: € 3,868 ▼ 12% vs 2022 (€ 4,385) Unchanged	€ 5,871 Land & buildings 2024: € 5,871 ▲ 52% vs 2023 (€ 3,868) Unchanged	€ 14,745 Land & buildings 2025: € 14,745 ▲ 151% vs 2024 (€ 5,871) Unchanged	▲ 151%
Retained profit	€ 98,754 Retained profit 2022: € 98,754 First fiscal year in the series	€ 98,754 Retained profit 2023: € 98,754 Unchanged (€ 98,754) Unchanged	€ 98,754 Retained profit 2024: € 98,754 Unchanged (€ 98,754) Unchanged	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 98,754) Unfavourable step	▼ 100%
Dividend	€ 103,434 Dividend 2022: € 103,434 First fiscal year in the series	€ 115,018 Dividend 2023: € 115,018 ▲ 11% vs 2022 (€ 103,434) Unchanged	€ 160,131 Dividend 2024: € 160,131 ▲ 39% vs 2023 (€ 115,018) Unchanged	€ 247,820 Dividend 2025: € 247,820 ▲ 55% vs 2024 (€ 160,131) Unchanged	▲ 55%
Bank debt	€ 9,354 Bank debt 2022: € 9,354 First fiscal year in the series	€ 627 Bank debt 2023: € 627 ▼ 93% vs 2022 (€ 9,354) Favourable step	€ 67 Bank debt 2024: € 67 ▼ 89% vs 2023 (€ 627) Favourable step	€ 67 Bank debt 2025: € 67 Unchanged (€ 67) Unchanged
Balance sheet total	€ 233,390 Balance sheet total 2022: € 233,390 First fiscal year in the series	€ 242,883 Balance sheet total 2023: € 242,883 ▲ 4% vs 2022 (€ 233,390) Unchanged	€ 290,692 Balance sheet total 2024: € 290,692 ▲ 20% vs 2023 (€ 242,883) Unchanged	€ 216,370 Balance sheet total 2025: € 216,370 ▼ 26% vs 2024 (€ 290,692) Unchanged	▼ 26%

Key figures of Dokter I de Wergifosse, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dokter I de Wergifosse?

What happened at Dokter I de Wergifosse in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 6, 2026 New annual accounts for financial year 2025: profit of € 149,066 (▼ 7% vs 2024). Source: NBB ↗
Oct 27, 2017 New establishment in Hasselt. KBO
Oct 27, 2017 Start of the company according to the CBE. KBO
2017 Isabelle de Wergifosse became a director. NBB

In short

From € 103,434 profit in 2022 to € 149,066 profit in 2025.

Paid € 157,312 in corporate taxes since 2022.

Best year ever: 2024, with € 160,131 profit.

Paid out € 626,403 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dokter I de Wergifosse? We notify you, reason included.

Follow Dokter I de Wergifosse

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Isabelle de Wergifosse

Dokter I de Wergifosse

SOCIETE ROYALE BELGE DE RHUMATOLOGIE KONINKLIJKE BELGISCHE VERENIGING VOOR REUMATOLOGIE

REUMA INSTITUUT

Behind Dokter I de Wergifosse is Isabelle de Wergifosse. Isabelle de Wergifosse is also behind SOCIETE ROYALE BELGE DE RHUMATOLOGIE KONINKLIJKE BELGISCHE VERENIGING VOOR REUMATOLOGIE and REUMA INSTITUUT.

See the full network in the app

Directors

According to the 2025 annual accounts

Isabelle de Wergifosse

Director

Also active at: SOCIETE ROYALE BELGE DE RHUMATOLOGIE KONINKLIJKE BELGISCHE VERENIGING VOOR REUMATOLOGIE, REUMA INSTITUUT

since 2017

Establishments

Establishment units

Physical locations of this company

Registered office

Sint-Truidersteenweg 109

3500 Hasselt

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0683.804.171
VAT number: BE 0683.804.171
Registered office: Sint-Truidersteenweg 109, 3500 Hasselt
Names & denominations: Dokter I de Wergifosse
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 27 October 2017
Peppol: Active · Active since 20 Jun 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗